Grupo Español Multidisciplinar De Melanoma
Clinical trials sponsored by Grupo Español Multidisciplinar De Melanoma, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New combo therapy aims to tackle melanoma that resists treatment Results expected Jun 2027 (estimated)
-
New combo therapy aims to tackle melanoma that resists treatment
Disease control OngoingThis phase 2 trial is testing whether a combination of two drugs, enfortumab vedotin and pembrolizumab, can shrink tumors in people with advanced melanoma that has worsened after standard therapy. The study will enroll 60 adults with unresectable stage III or IV melanoma. Researc…
Phase 2 • Sponsor: Grupo Español Multidisciplinar de Melanoma • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Real-World melanoma care under the microscope
Knowledge-focused OngoingResearchers are studying how advanced and metastatic melanoma is diagnosed and treated in everyday Spanish clinics. The study follows about 400 adults with stage III, metastatic, or unresectable melanoma from their first diagnosis. No experimental treatment is given; instead, the…
Sponsor: Grupo Español Multidisciplinar de Melanoma • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC